About Golgi pH regulator B
Golgi pH regulator B (GPR89B) is a protein
from Homo sapiens identified by UniProt accession
P0CG08, 455 residues long.
MolForge cross-references it against 0 known binders and
27 disease associations.
Target properties
| Protein name | Golgi pH regulator B |
| UniProt accession | P0CG08 |
| Gene | GPR89B |
| Organism | Homo sapiens |
| Length | 455 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (27)
Diseases linked to this target (Open Targets).
- urate measurement · score 0.15
- hemoglobin measurement · score 0.05
- Okt4 epitope deficiency · score 0.05
- hematocrit · score 0.05
- erythrocyte count · score 0.05
- red blood cell density measurement · score 0.04
- atrial fibrillation · score 0.04
- mean corpuscular hemoglobin concentration · score 0.04
- combined immunodeficiency with skin granulomas · score 0.03
- Peptic ulcer · score 0.03
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P0CG08-F1 | alphafold | PREDICTED | 82.51 | — |
Amino-acid sequence (455 residues)
MSFLIDSSIM ITSQILFFGF GWLFFMRQLF KDYEIRQYVV QVIFSVTFAF SCTMFELIIF EILGVLNSSS RYFHWKMNLC VILLILVFMV PFYIGYFIVS NIRLLHKQRL LFSCLLWLTF MYFFWKLGDP FPILSPKHGI LSIEQLISRV GVIGVTLMAL LSGFGAVNCP YTYMSYFLRN VTDTDILALE RRLLQTMDMI ISKKKRMAMA RRTMFQKGEV HNKPSGFWGM IKSVTTSASG SENLTLIQQE VDALEELSRQ LFLETADLYA TKERIEYSKT FKGKYFNFLG YFFSIYCVWK IFMATINIVF DRVGKTDPVT RGIEITVNYL GIQFDVKFWS QHISFILVGI IIVTSIRGLL ITLTKFFYAI SSSKSSNVIV LLLAQIMGMY FVSSVLLIRM SMPLEYRTII TEVLGELQFN FYHRWFDVIF LVSALSSILF LYLAHKQAPE KQMAP
Explore Golgi pH regulator B with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets